The impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial: An institutional review
详细信息 查看全文
- 作者：Viet H. Lea ; VLe@ghs.org" class="auth_mail" title="E-mail the corresponding author ; Kathleen N. Branta ; Dawn W. Blackhursta ; Christine M.G. Schammelb ; David P. Schammelb ; Wendy R. Cornetta ; Brian P. McKinleya
- 关键词：ACOSOG Z0011 trial ; Axillary lymph node dissection ; Sentinel lymph node biopsy
- 刊名：The Breast
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：29
- 期：Complete
- 页码：117-119
- 全文大小：180 K
文摘
- •
Following the ACOSOG Z0011 trial, omission of axillary dissection (AD) was recommended for select patients with a positive sentinel node (SN+).
- •
Our data indicate patient age (≥T2) or staging, and surgical treatment choice influence surgeon's decision to perform ALND.
- •
The results of our data support recent publications and indicate the ACOSOG Z0011 trial to be practice-changing.